These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7609506)

  • 21. Discussion on the natriuretic effect of calcium antagonists.
    Zanchetti A; Leonetti G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S161-4. PubMed ID: 2442510
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic hypertension and antihypertensive agents.
    Maschio G; Marcantoni C; Bernich P
    J Nephrol; 1999; 12 Suppl 2():S100-4. PubMed ID: 10688408
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium channel blockers and nephroprotection.
    Ungar A; Di Serio C; Lambertucci L; Monami M; Masotti G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):31-9. PubMed ID: 16640171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilators, antihypertensive therapy and the kidney.
    Hollenberg NK
    Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M; Biollaz J; Steinhauslin F; Brouard R; Waeber B; Brunner HR
    Clin Invest Med; 1991 Dec; 14(6):581-9. PubMed ID: 1686579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-1-induced vasopressor responses in essential hypertension.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing renal effects and renal protection.
    Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1995 Dec; 13(4):S19-25. PubMed ID: 8824683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium antagonists: current and future applications based on new evidence. Renal protective action of calcium channel blockers].
    Kimura G
    Clin Calcium; 2010 Jan; 20(1):94-9. PubMed ID: 20048440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of antihypertensive therapy on renal function.
    Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
    J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium antagonists and the kidney.
    Pearce CJ; Wallin JD
    New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists and their potential for antihypertensive therapy.
    Bühler FR; Kiowski W
    Ann N Y Acad Sci; 1988; 522():584-99. PubMed ID: 3288062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
    Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
    Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kidney and strategies for the treatment of hypertension.
    Hollenberg NK
    Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.